One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...

Primary nephrotic syndrome in adults, including minimal-change nephrotic syndrome, has an incidence of roughly 0.2 to 0.8 per ...

Researchers from The University of Osaka have found that rituximab, a monoclonal antibody approved for the treatment of ...

Natasha Murphy, director of health policy at the Center for American Progress, said the situation risks pricing younger ...

Chronic urticaria affects 17% of patients, with higher age, elevated BMI, and early prednisolone use as key determinants of prolonged disease duration. The study utilized data from the Julius General ...

TENS of thousands of people in England suffering from debilitating eczema could soon be free of agonising symptoms after a ...

The condition, which most often affects people in warm, humid climates where fungal spores are common, can trigger nasal ...

What are called autoimmune diseases can affect just about every part of the body – and tens of millions of people. While most ...

Sparsentan therapy was associated with sustained decline in proteinuria and lower likelihood of progression to kidney failure ...

For most of us, the phrase "stroke of the eye" sounds like a metaphor. But for UK HealthCare's Jagannadha "Jay" Avasarala, ...